We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.14 | -6.86% | 1.90 | 1.84 | 1.96 | 2.01 | 2.00 | 2.00 | 1,925,128 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.76 | 6.7M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/12/2017 09:21 | Hard to believe that with this rise there isn't a major sniffing around. It's a big game if chicken now, they could try to get Lupuzor for £1bn now, or wait and be in a battle to pay ten times that by spring. | mad foetus | |
11/12/2017 09:18 | Market cap still a miserly £215m..... That would be about right for the pipeline EXCLUDING Lupuzor IMO. DYOR etc. | qazwsxedc69 | |
11/12/2017 09:17 | going very nicely indeed.... | qs99 | |
11/12/2017 09:04 | indeed...£2 and beyond looks very doable at this rate IMO...DYOR | qs99 | |
11/12/2017 09:02 | they can't keep up with demand | adejuk | |
11/12/2017 09:02 | £1.60 Gone! | spmc | |
11/12/2017 08:54 | I agree with Ham.. The spread seems to be quite wide on this one and with an upwards trend it might cost a fair bit to buy back. I bought some VELA this morning (actually lodged it over the weekend) and ended up paying 15% above because of the spread. | tricky red | |
11/12/2017 08:50 | Yep, if you try profit taking and re-entry on this share, you are going to get caught out. This share is more gappy than Terry Thomas' front teeth (god rest is wonderful soul) | hamhamham1 | |
11/12/2017 08:50 | The risk reward here is unbelievable. I've only taken a small stake but this is surely a share everyone should have a nibble from. | mad foetus | |
11/12/2017 08:46 | I had a target of £2.50-£5 | divinessence | |
11/12/2017 08:37 | Grabbed a few more. IMM is the one to be in. | top tips | |
11/12/2017 08:26 | Have you been topping up top tips? LOL | flavio_monteiro | |
11/12/2017 08:19 | This is just the start. Its worth billions. | top tips | |
11/12/2017 08:19 | I'm not selling any NYBoy for a long while don't worry. This is a hold extremely tight for me. | spawny100 | |
11/12/2017 08:18 | With most now completed the trial.looks like it could be good news next quarter | fidra | |
11/12/2017 08:17 | Just hold until next Spring for substantive returns imho Starting to warm up now on a cold blighty day. | ny boy | |
11/12/2017 08:12 | Volume started out with a bang this morning | spawny100 | |
11/12/2017 08:11 | Only dear the day you buy it :-) | che7win | |
11/12/2017 08:08 | Bit perky this morning for a dark damp cold Monday | spawny100 | |
11/12/2017 08:04 | 175p next target | herschel k | |
10/12/2017 22:25 | Edit: Majority of the patients showed resolution of the arthritis measure (4 point score). | money maker1 | |
10/12/2017 22:23 | An analyst said they understood the arthritis measures were "completely resolved" in the Phase 2b Lupuzor trial. | money maker1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions